Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

Clinical trial NCT07372989 · RECRUITING

Trial details

NCT number: NCT07372989
Sponsor: Maule Stem Cell Research Institute, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2026-02-01
Primary completion: 2027-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.